Proton Therapy Effective Prostate Cancer Treatment

	Tweet

Proton therapy, a type of external beam radiation therapy, is a safe and effective treatment for prostate cancer, according to two new studies published in the January issue of the International Journal of Radiation Oncology•Biology•Physics (Red Journal), the American Society for Radiation Oncology’s (ASTRO) official scientific journal.

In the first study, researchers at the University of Florida in Jacksonville, Fla., prospectively studied 211 men with low-, intermediate-, and high-risk prostate cancer. The men were treated with proton therapy, a specialized type of external beam radiation therapy that uses protons instead of X-rays. After a two year follow-up, the research team led by Nancy Mendenhall, MD, of the University of Florida Proton Therapy Institute, reported that the treatment was effective and that the gastrointestinal and genitourinary side effects were generally minimal.

“This study is important because it will help set normal tissue guidelines in future trials,” Dr. Mendenhall, said. 

In the second study, researchers from Massachusetts General Hospital in Boston, Loma Linda University Medical Center in Loma Linda, Calif., and the Radiation Therapy Oncology Group in Philadelphia performed a case-matched analysis comparing high-dose external beam radiation therapy using a combination of photons (X-rays) and protons with brachytherapy (radioactive seed implants).

Over three years, 196 patients received the external beam treatments. Their data was compared to 203 men of similar stages who received brachytherapy over the same time period. Researchers then compared the biochemical failure rates (a statistical measure of whether the cancer relapses) and determined that men who received the proton/photon therapy had the same rate of recurrence as the men who received brachytherapy.

“For men with prostate cancer, brachytherapy and external beam radiation therapy using photons and protons are both highly effective treatments with similar relapse rates,” John J. Coen, MD, a radiation oncologist at Massachusetts General Hospital in Boston, said. “Based on this data, it is our belief that men with prostate cancer can reasonably choose either treatment for localized prostate cancer based on their own concerns about quality of life without fearing they are compromising their chance for a cure.”

Red Journal Editor-in-Chief Anthony L. Zietman, MD, FASTRO, is a co-author on the second study.

ASTRO is the largest radiation oncology society in the world, with more than 10,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy.

###

Source: American Society for Radiation Oncology (ASTRO)

RELATED STORIES:
Researchers find new biomarker for fatal prostate cancer   Scientists see progress in prostate cancer tests   Prostate Cancer: Watchful Wait or Vaccinate?   Dehydrated tomatoes show promise for preventing prostate cancer   Why Prostate Cancer Patients Fail Hormone Deprivation   Mediterranean Diet May Help Prevent Prostate Cancer   Low PSA may not rule out prostate cancer   Stem Cells Found in Prostate May Be Involved in Cancer   Fewer complications, better outcomes with robot-assisted prostate cancer surgery   Men who stay trim less apt to get prostate cancer   Prostate cancer hormone therapy hard on the heart   Predictive model of prostate cancer risk   Hormonal Dietary Supplements Might Promote Prostate Cancer Progression   Aspirin, Other NSAIDs, May Prevent or Delay Enlarged Prostate   Trio of studies support use of PET/CT scans as prostate cancer staging tool   Selenium-Protein Deficiency Raises Prostate Cancer Risk   Patients who refuse prostate cancer surgery have worse long-term survival   Black men least likely to get prostate cancer screening even during peak ages of risk   Why a common treatment for prostate cancer ultimately fails   Older men get less effective prostate cancer care   New research model of human prostate cancer shows cancer development   New, Non-invasive Prostate Cancer Test Beats PSA in Detecting Prostate Cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]